Edition:
United Kingdom

People: Glenmark Pharmaceuticals Ltd (GLEN.NS)

GLEN.NS on National Stock Exchange of India

374.10INR
7:49am BST
Change (% chg)

Rs0.05 (+0.01%)
Prev Close
Rs374.05
Open
Rs371.25
Day's High
Rs378.60
Day's Low
Rs371.25
Volume
425,980
Avg. Vol
1,181,517
52-wk High
Rs705.90
52-wk Low
Rs353.50

Mani, V. S. 

Mr. V. S. Mani serves as Global Chief Financial Officer, Executive Director of the Company. Mr. Mani leads the organisation’s worldwide finance operations and secretarial function, including global accounting, financial reporting, tax and treasury. He has over 25 years of rich industry experience across treasury, taxation, accounting, financial planning & analysis, secretarial, legal, audits, risk management and investor relations. Prior to joining Glenmark in 2017, he was the President Finance at the Bhartiya Group. He has also held the position of the Chief Financial Officer at Cipla.

Basic Compensation

Total Annual Compensation, INR 12,900,000
Restricted Stock Award, INR --
Long-Term Incentive Plans, INR --
All Other, INR 8,240,000
Fiscal Year Total, INR 21,140,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Glenn Saldanha

161,620,000

V. S. Mani

21,140,000

Harish Kuber

2,750,000

Cherylann Pinto

42,940,000

Rajesh Desai

1,200,000

Blanche Saldanha

400,000
As Of  31 Mar 2018